Related references
Note: Only part of the references are listed.Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T-cell lymphoma: A randomized, controlled, open-label, multicenter study
Lei Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Using etoposide plus dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis
Liqiang Wei et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group
Shu-Nan Qi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patients
Yizhen Liu et al.
CANCER MEDICINE (2020)
Pegaspargase Combined with Concurrent Radiotherapy forEarly-StageExtranodal Natural Killer/T-CellLymphoma, Nasal Type: ATwo-CenterPhaseIIstudy
Hua Wang et al.
ONCOLOGIST (2020)
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type
Liqiang Wei et al.
LEUKEMIA RESEARCH (2020)
Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type
Shu Tian et al.
CANCER MEDICINE (2019)
Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas
Eric Tse et al.
EXPERT REVIEW OF HEMATOLOGY (2019)
A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas
Xuyan Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma
Xin Liu et al.
JAMA NETWORK OPEN (2019)
Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution
Chun Cao et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2018)
Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review
Seok Jin Kim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/IINK/T-cell lymphoma
Y. L. Kwong et al.
ANNALS OF ONCOLOGY (2018)
A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China
Rong Liang et al.
HEMATOLOGICAL ONCOLOGY (2017)
Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma
Shinichi Makita et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type
Peng-Peng Xu et al.
EBIOMEDICINE (2017)
Five-year analysis from phase 2 trial of sandwich chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Li Zhang et al.
CANCER MEDICINE (2016)
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas
Bo Jia et al.
HEMATOLOGY (2016)
Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma
Xiao-mei Jing et al.
LEUKEMIA RESEARCH (2016)
Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma
Jing-hua Wang et al.
ONCOTARGET (2016)
Management of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Ranjit Kumar Chaudhary et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study
Hao Ding et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Joachim Yahalom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients
Zhiyuan Zhou et al.
ANNALS OF HEMATOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A study of gemcitabine, L-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type
Jie Ji et al.
LEUKEMIA & LYMPHOMA (2014)
Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up
Wang Liang et al.
MEDICAL ONCOLOGY (2014)
First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
Liang Wang et al.
CANCER (2013)
Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma
Hee Kyung Ahn et al.
INVESTIGATIONAL NEW DRUGS (2013)
A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
Ningjing Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Distribution of Lymphoid Neoplasms in China Analysis of 4,638 Cases According to the World Health Organization Classification
Jian Sun et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong et al.
BLOOD (2012)
Phase 2 trial of Sandwich L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Ming Jiang et al.
CANCER (2012)
MILD TOXICITY AND FAVORABLE PROGNOSIS OF HIGH-DOSE AND EXTENDED INVOLVED-FIELD INTENSITY-MODULATED RADIOTHERAPY FOR PATIENTS WITH EARLY-STAGE NASAL NK/T-CELL LYMPHOMA
Hua Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution
Qun-Pei Yang et al.
DIAGNOSTIC PATHOLOGY (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
Norbert Schmitz et al.
BLOOD (2010)
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Seok Jin Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Selective apoptosis of natural killer-cell tumours by L-asparaginase
M Ando et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Share Paper
